Senior Director, Launch & Lifecycle Management Excellence, Cell Therapy Supply Chain

Job description

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us. The Senior Director, Cell Therapy Launch & Lifecycle Management Excellence leads the global strategy, governance, and execution oversight of Launch Excellence capabilities across the Cell Therapy portfolio. The role is responsible for defining and advancing the long-term launch excellence roadmap, ensuring seamless alignment across Product Development, Operations, Supply Chain, Regulatory, Quality, and Commercial organizations to enable successful product launches and lifecycle changes worldwide. The role serves as the central point of integration between development, manufacturing, supply chain, and commercial organizations to ensure launch readiness, portfolio prioritization, resource alignment, risk management, and execution excellence across all Cell Therapy assets. The Senior Director leads a team of Launch Excellence Managers & Professionals and establishes the operating model, governance, and digital capabilities necessary to support current and future portfolio growth while driving continuous improvement and responsible AI adoption. Key Responsibilities: Strategy & Enterprise Launch Governance Define and maintain the global Launch Excellence strategy across the Cell Therapy portfolio. Develop and execute a multi-year Launch Excellence capability roadmap focused on scalability, operational excellence, and future portfolio growth. Establish a single source of truth for all Cell Therapy launch and lifecycle initiatives. Lead launch governance processes, portfolio prioritization, and executive escalation frameworks. Define launch performance measures, KPIs, and portfolio health metrics to drive decision-making and continuous improvement. Promote responsible AI adoption and digital innovation to enhance launch planning, forecasting, risk management, and execution. Portfolio Launch Planning & Execution Provide strategic oversight for all Cell Therapy launch and lifecycle management programs. Ensure launch readiness across product development, manufacturing, quality, regulatory, supply chain, and commercial organizations. Oversee launch scenario planning, portfolio sequencing, resource planning, and risk mitigation activities. Lead launch forecasting and supply readiness assessments to inform portfolio investment and business decisions. Establish processes to identify emerging risks, capacity constraints, and execution challenges across the launch portfolio. Ensure post-launch performance monitoring and capture lessons learned to drive future launch excellence. Product Obsolescence Process & Execution Framework Develop and operationalize a Product Obsolescence Process & Execution Framework across the Cell Therapy portfolio to proactively manage product, market, material, and lifecycle discontinuation scenarios. Define governance, decision rights, stage gates, and escalation pathways for obsolescence planning, risk assessment, approval, and execution. Establish an end-to-end execution playbook covering inventory disposition, regulatory and quality dependencies, commercial alignment, and stakeholder communications. Partner with Product Development, Supply Chain, Manufacturing, Regulatory, Quality, Finance, and Commercial teams to identify obsolescence triggers, assess patient and business impact, and coordinate mitigation plans. Create standardized tools, templates, metrics, and executive reporting mechanisms to monitor obsolescence readiness, track execution progress, capture risks, and embed lessons learned into future lifecycle management practices. Cross-Functional Leadership & Business Integration Serve as the primary interface between Cell Therapy Operations, Development, Supply Chain, Commercial, Regulatory, Quality, and Finance organizations for launch strategy and governance. Enable alignment across global and regional leadership teams regarding launch priorities, tradeoffs, timelines, and risk management. Influence enterprise decision-making through executive-level communication and presentation of launch risks, opportunities, and strategic recommendations. Partner with Commercial organizations to ensure alignment between market demand strategies and supply readiness plans. Collaborate with manufacturing sites, product leaders, supply planning, regulatory, and quality organizations to ensure successful execution of launch commitments. Organizational Capability Building Build and lead a high-performing Launch Excellence organization. Define future-state operating models, organizational capabilities, tools, systems, and governance frameworks required to support pipeline growth. Establish Launch Excellence standards, playbooks, methodologies, training programs, and best practices. Create and sustain a culture of accountability, innovation, simplification, and continuous improvement. Develop talent pipelines and succession plans to ensure organizational sustainability. Qualifications & Experience: B.S. or B.A. in science and/or engineering (biotechnology, biology, engineering or related sciences). Master or advanced degree (sciences or business) and prior cell therapy development experience preferred. 15+ years of biopharmaceutical industry experience across product development, manufacturing, supply chain, operations, quality, regulatory, commercial, and/or technology functions. Demonstrated leadership of complex global product launches and lifecycle management programs. Experience leading enterprise initiatives across highly matrixed organizations. Strong understanding of Cell Therapy product development, launch readiness, lifecycle management, and supply chain processes Proven ability to influence executive-level stakeholders, including Vice Presidents, General Managers, and functional leaders. Demonstrated success building organizational capabilities and leading transformational change. Strong business and financial acumen with the capability to evaluate tradeoffs and drive strategic decisions. Demonstrated expertise in critical thinking, influence, negotiation, problem solving, strategic thinking and leadership in a matrix environment. Certification or exposure to Operational Excellence/Continuous Improvement concepts desirable. Ability to provide innovative ideas to optimize supply chain and generate new ideas or alternatives that create value, including seeking new information and external insights. Exceptional communication, negotiation, and stakeholder management skills. #LI-Hybrid BMSCART If you come across a role that intrigues you but doesn’t perfectly line up with your resume, we encourage you to apply anyway. You could be one step away from work that will transform your life and career. Compensation Overview: Devens - MA - US: $234,180 - $283,775 Madison - Giralda - NJ - US: $218,870 - $265,215 Princeton - NJ - US: $218,870 - $265,215 Seattle - WA: $240,750 - $291,727 The starting compensation range(s) for this role are listed above for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into accoun